1. Home
  2. INTT vs RVPH Comparison

INTT vs RVPH Comparison

Compare INTT & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$7.40

Market Cap

94.9M

Sector

Technology

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.28

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
RVPH
Founded
1981
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.9M
71.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INTT
RVPH
Price
$7.40
$0.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$12.00
$3.33
AVG Volume (30 Days)
35.2K
8.4M
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,606,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$0.25
52 Week High
$9.77
$2.17

Technical Indicators

Market Signals
Indicator
INTT
RVPH
Relative Strength Index (RSI) 47.49 27.92
Support Level $7.25 $0.25
Resistance Level $7.62 $0.34
Average True Range (ATR) 0.36 0.07
MACD 0.03 -0.04
Stochastic Oscillator 44.62 5.23

Price Performance

Historical Comparison
INTT
RVPH

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: